Europe PMC

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Immunotherapy: HLA genotype: good to be different.

Author information

ORCIDs linked to this article

Nature reviews. Immunology, 27 Dec 2017, 18(2):78-79
https://doi.org/10.1038/nri.2017.220 PMID: 29279611 

This is a comment on "Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy." Science. 2018 Feb 2;359(6375):582-587.

Abstract 

No abstract provided.

Full text links 

Read article at publisher's site: https://doi.org/10.1038/nri.2017.220

References 

Articles referenced by this article (1)

Citations & impact 

Impact metrics

1
Citation
Jump to Citations

Alternative metrics

Altmetric item for https://www.altmetric.com/details/30961584
Altmetric
Discover the attention surrounding your research
https://www.altmetric.com/details/30961584

Smart citations by scite.ai
Smart citations by scite.ai include citation statements extracted from the full text of the citing article. The number of the statements may be higher than the number of citations provided by EuropePMC if one paper cites another multiple times or lower if scite has not yet processed some of the citing articles.
Explore citation contexts and check if this article has been supported or disputed.
https://scite.ai/reports/10.1038/nri.2017.220

Supporting
Mentioning
Contrasting
0
1
0

Article citations

Similar Articles 

To arrive at the top five similar articles we use a word-weighted algorithm to compare words from the Title and Abstract of each citation.